COVID-19 Vaccine Combos Aim to Boost Immunity
COVID-19 Vaccine Combos Aim to Boost Immunity
Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.
COVID-19 Vaccine Combos Aim to Boost Immunity
COVID-19 Vaccine Combos Aim to Boost Immunity

Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.

Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.

news feature
What Pseudoviruses Bring to the Study of SARS-CoV-2
What Pseudoviruses Bring to the Study of SARS-CoV-2
Amanda Heidt | Feb 16, 2021
Engineered viruses that don’t replicate provide a tractable model for scientists to safely study SARS-CoV-2, including research into vaccine efficacy and emerging variants.
Vaccines Versus the Mutants
Vaccines Versus the Mutants
Anthony King | Feb 8, 2021
Facing new variants of SARS-CoV-2, some vaccines may offer more robust protection or be more easily redesigned to target them.
Will Delaying Vaccine Doses Cause a Coronavirus Escape Mutant?
Will Delaying Vaccine Doses Cause a Coronavirus Escape Mutant?
Chris Baraniuk | Feb 4, 2021
With many millions of people waiting several weeks to receive a second COVID-19 vaccine dose in some countries, experts consider the possibility that SARS-CoV-2 could evolve vaccine resistance.
Reduced Adult Neurogenesis Linked with Alzheimer’s Disease
Reduced Adult Neurogenesis Linked with Alzheimer’s Disease
Abby Olena | Feb 1, 2021
Manipulating the production of new neurons can improve cognition in animal models of the disease, raising the possibility that figuring out a way for humans to make more neurons could make a difference for people with dementia.
Special report
A Guide to Emerging SARS-CoV-2 Variants
A Guide to Emerging SARS-CoV-2 Variants
Katarina Zimmer | Jan 26, 2021
Scientists across the world are closely tracking the spread of mutations in the coronavirus and investigating whether they could render current vaccines less effective.
SARS-CoV-2 Isn’t Going Away, Experts Predict
SARS-CoV-2 Isn’t Going Away, Experts Predict
David Adam | Jan 25, 2021
As politicians try to schedule an end to the pandemic, scientists say the virus will stick around as an endemic disease similar to the common cold.
Special Report
COVID-19’s Effects on the Brain
COVID-19’s Effects on the Brain
Katarina Zimmer | Jan 20, 2021
Autopsy studies have yet to find clear evidence of destructive viral invasion into patients’ brains, pushing researchers to consider alternative explanations of how SARS-CoV-2 causes neurological symptoms.
RNA Interference Comes of Age
RNA Interference Comes of Age
Diana Kwon | Dec 9, 2020
The third FDA approval of an RNAi-based therapeutic marks the growing success of a technique that took two decades to get off the ground.
AI-Assisted Cough Tracking Could Help Detect the Next Pandemic
AI-Assisted Cough Tracking Could Help Detect the Next Pandemic
Max Kozlov | Dec 6, 2020
Some researchers have turned their focus to artificial intelligence to study an underused symptom common to most respiratory pathogens—cough.